Publication:
Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin

dc.contributor.authorLinlin Wangen_US
dc.contributor.authorLiang Lien_US
dc.contributor.authorYujiao Sunen_US
dc.contributor.authorYe Tianen_US
dc.contributor.authorYing Lien_US
dc.contributor.authorConghao Lien_US
dc.contributor.authorVaraporn B. Junyapraserten_US
dc.contributor.authorShirui Maoen_US
dc.contributor.otherShenyang Pharmaceutical Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T05:42:58Z
dc.date.available2018-10-19T05:42:58Z
dc.date.issued2013-09-27en_US
dc.description.abstractThe objective of this paper is to elucidate the influence of lipophilic modification degree of chitosan on the peroral absorption of enoxaparin. A series of novel chitosan grafted glyceryl monostearate (GM) copolymers with different GM substitution degree were synthesized and the successful synthesis was confirmed by1H NMR, FTIR and X-ray diffraction. Enoxaparin loaded nanocomplexes with different carriers were prepared by self-assembly process. Influence of GM substitution degree and chitosan molecular weight in the copolymer on the properties of the nanocomplexes was investigated. Morphology of the nanocomplexes was observed by atomic force microscopy. Mucoadhesive properties of the nanocomplexes were characterized using mucin particle method. Initially, mucoadhesion of the nanocomplexes increased with the increase of GM substitution degree and it started to decrease when the substitution degree was up to 18.6%. A good linear relationship between GM substitution degree and in vivo absorption of enoxaparin in fasted rats was established in the substitution degree range of 0-11.1%. In agreement with mucoadhesion data, further increasing GM substitution degree to 18.6% caused a decrease in oral absorption. In conclusion, oral bioavailability of enoxaparin can be enhanced by structure modification of the carriers and the bioavailability is hydrophobic modification degree dependent. © 2013 Elsevier B.V. All rights reserved.en_US
dc.identifier.citationEuropean Journal of Pharmaceutical Sciences. Vol.50, No.3-4 (2013), 263-271en_US
dc.identifier.doi10.1016/j.ejps.2013.07.009en_US
dc.identifier.issn18790720en_US
dc.identifier.issn09280987en_US
dc.identifier.other2-s2.0-84884514812en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/32730
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84884514812&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleExploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparinen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84884514812&origin=inwarden_US

Files

Collections